PODD
Medical Devices · Healthcare
Analyst
UBS
Analyst
SVB Leerink
Analyst
SVB Securities
Equibles does not estimate personal net worth.
Danielle Antalffy is recorded as Analyst at UBS, Analyst at SVB Leerink and Analyst at SVB Securities. Danielle Antalffy has spoken on 16 earnings calls across 10 companies, most recently for Sight Sciences, Inc. on March 4, 2026. Those appearances were for Insulet Corp (PODD), GLAUKOS Corp (GKOS), Sight Sciences, Inc. (SGHT), Johnson & Johnson (JNJ), RxSight, Inc. (RXST) and 5 other companies. The companies whose calls Danielle Antalffy spoke on are classified in the Healthcare sector.
“Just a question on the standalone glaucoma market. I'm just curious what you see or how you see this evolving in the near term. I was at AO back in October. It seems to be very much a focus, and I'm a big believer in the standalone glaucoma market.”
“Just a question, just to get a little bit deeper into the international opportunity here. I'm just curious if you could talk a little bit.”
“I imagine we are going to get this more for this tomorrow. But, Larry, I'm just curious, in the six months or so that you've been there, you know, how much of a heavy lift do you think the market development component is here?”
“So my question is on the competitive mode. Ashley, you touched on this earlier. I do think it's underappreciated.”
“I'll echo everyone's strong end to the year, and happy new year. Just a question on this move to higher growth and markets. Appreciate that you've done a lot of and are doing a lot of portfolio pruning now.”
UBS
Analyst
Source not stated
SVB Leerink
Analyst
Source not stated
SVB Securities
Analyst
Source not stated
PODD
Medical Devices · Healthcare
GKOS
Medical Devices · Healthcare
SGHT
Medical Devices · Healthcare
Drug Manufacturers - General · Healthcare
RXST
Medical Devices · Healthcare
DXCM
Medical Devices · Healthcare
Medical Instruments & Supplies · Healthcare